Baker Bros. Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,406,037
Closed -$8.87M 131
2021
Q2
$8.87M Hold
1,406,037
0.04% 80
2021
Q1
$8.69M Hold
1,406,037
0.04% 80
2020
Q4
$9.72M Hold
1,406,037
0.04% 75
2020
Q3
$7.93M Sell
1,406,037
-229,464
-14% -$1.09M 0.03% 71
2020
Q2
$8.34M Hold
1,635,501
0.04% 67
2020
Q1
$5.63M Buy
1,635,501
+1,493,751
+1,054% +$8.73M 0.03% 64
2019
Q4
$1.22M Buy
+141,750
New +$506K 0.01% 91
2016
Q4
Sell
-35,649
Closed -$1.64M 137
2016
Q3
$1.64M Hold
35,649
0.01% 101
2016
Q2
$1.82M Hold
35,649
0.02% 100
2016
Q1
$1.51M Hold
35,649
0.02% 107
2015
Q4
$2.8M Hold
35,649
0.02% 98
2015
Q3
$1.44M Hold
35,649
0.01% 112
2015
Q2
$1.86M Hold
35,649
0.02% 103
2015
Q1
$1.66M Sell
35,649
-1,127
-3% -$58.5K 0.01% 111
2014
Q4
$1.65M Hold
36,776
0.02% 103
2014
Q3
$1.43M Hold
36,776
0.02% 93
2014
Q2
$1.56M Hold
36,776
0.02% 94
2014
Q1
$1.31M Sell
36,776
-66,264
-64% -$2.24M 0.02% 94
2013
Q4
$3.33M Buy
+103,040
New +$3.06M 0.05% 72

Other funds holding ISEE

Baker Bros. Advisors's ISEE Position: Q3 2021 in Review

Baker Bros. Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2021, closing a stake of 1,406,037 shares — an estimated $8.87M sold.

Baker Bros. Advisors first reported a position in ISEE in Q4 2013 and held it in 19 quarters. The position peaked at $9.72M in Q4 2020. 149 funds tracked by Wall St. Rank hold ISEE as of Q3 2021.

  • Baker Bros. Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Baker Bros. Advisors sold 1,406,037 IVERIC bio, Inc. Common Stock shares in Q3 2021, an estimated $8.87M.
  • Baker Bros. Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 19 quarters.
  • Baker Bros. Advisors's IVERIC bio, Inc. Common Stock position peaked at $9.72M in Q4 2020.
  • 149 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2021.

Based on Baker Bros. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.